Correction of the Allan-Herndon-Dudley syndrome-causing SLC16A2 mutation G401R in a patient derived hiPSC line
The X-linked Allan-Herndon-Dudley syndrome (AHDS) is a genetic disorder characterized by severe psychomotor impairment, resulting from mutations in the SLC16A2 gene, which encodes the thyroid hormone transporter MCT8 (monocarboxylate transporter 8). Previously, we established a hiPSC line from a patient carrying the SLC16A2:R401G mutation (BIHi045-A). Using CRISPR/Cas9-mediated gene editing, we targeted exon 3 of SLC16A2 and used single-stranded oligodeoxynucleotides as homology-directed repair templates to correct the R401G missense mutation, generating an isogenic control cell line.
Authors
- Matthias Megges
- Harald Stachelscheid (ORCID: https://orcid.org/0000-0002-9283-4605)
- Katarzyna A. Ludwik
- Peter Kühnen (ORCID: https://orcid.org/0000-0003-0211-176X)
- Robert Opitz (ORCID: https://orcid.org/0000-0003-3143-0997)
- Sabine Jyrch
Institutions
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Stem Cell Research
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1016/j.scr.2025.103698
- Primary Topic
- Genetics and Neurodevelopmental Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Forschungsgemeinschaft
- European Research Council